convenia- cefovecin sodium injection, powder, lyophilized, for solution
zoetis inc. - cefovecin sodium (unii: dl8q24959p) (cefovecin - unii:0d1ol46zie) - cefovecin 80 mg in 1 ml - dogs convenia is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of staphylococcus intermedius and streptococcus canis (group g). cats convenia is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of pasteurella multocida . convenia is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. anaphylaxis has been reported with the use of this product in foreign market experience. if an allergic reaction or anaphylaxis occurs, convenia should not be administered again and appropriate therapy should be instituted. anaphylaxis may require treatment with epinephrine and other emergency measures, including oxygen, intravenous fluids, intravenous antihistamine, corticosteroids, and airway management, as clinically indicated. adverse reactions may require prolonged treatment due to the prol
cefovecin sodium
zoetis australia pty ltd - cefovecin as cefovecin sodium - unknown - cefovecin as cefovecin sodium antibiotic active 0.0 - active constituent
convenia
zoetis new zealand limited - cefovecin present as cefovecin sodium - cefovecin present as cefovecin sodium 80 g/litre - antibiotic
convenia
zoetis australia pty ltd - cefovecin as sodium salt - parenteral liquid/solution/suspension - cefovecin as sodium salt antibiotic active 80.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacterial skin disease | escherichia coli (e. coli) | infections of the urinary tracts | infections sensitive to cefovecin | porphyromonas spp | prevotella spp | proteus mirabilis | staphylococcus intermedius | streptococcus canis | deep pyodermas | escherichia coli | group d streptococcus | including b-lactamase producin | including secondary invaders | klebsiella spp. | proteus spp. | pseudomonas aeruginosa | seborrhoeic dermatitis | staphylococcus spp.
convenia kit
zoetis canada inc - cefovecin (cefovecin sodium) - kit - 80mg - cefovecin (cefovecin sodium) 80mg - cats; dogs
convenia
zoetis belgium sa - cefovecin (as sodium salt) - antibacterials for systemic use - dogs; cats - dogsfor the treatment of skin and soft-tissue infections including pyoderma, wounds and abscesses associated with staphylococcus pseudintermedius, β-haemolytic streptococci, escherichia coli and / or pasteurella multocida.for the treatment of urinary-tract infections associated with escherichia coli and / or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with porphyromonas spp. and prevotella spp.catsfor the treatment of skin and soft-tissue abscesses and wounds associated with pasteurella multocida, usobacterium spp., bacteroides spp., prevotella oralis, β-haemolytic streptococci and / or staphylococcus pseudintermedius.for the treatment of urinary-tract infections associated with escherichia coli.
convenia 80mgml powder for solution for injection for dogs and cats
zoetis malaysia sdn. bhd. - cefovecin sodium -
convenia powder for injection
zoetis belgium s.a., belgium - cefovecin - powder for injection - 851.98 mg/ml
convenia 80 mg/ml powder and solvent for solution for injection for dogs and cats
zoetis uk limited - cefovecin - powder and solvent for solution for injection - antimicrobial - cats, dogs
convenia veterinary
zoetis israel holding b.v., israel - cefovicin as sodium salt - powder and solvent for solution for injection - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.